@ricky_bankerHow are you doing?
Prof ZR appointment is to accelerate Nasdaq listing, not cfda.
Like many here we are frustrated with delays, and some have bailed out, 1%.
I have not let go of any.
If 10%, 20% or 30% of 137m (quoted on asx out of ~410m shares issued) had sold out, then i will be concerned .
Obviously 99% are prepared to wait.
I can only speak for myself coz i dont know anyone else financial situation.
As mentioned, i watched Xero sp movement from nzx IPO first day:
$1, 60c, 80c, drifting nowhere, but after *New Investors bought in, sp bounced from 80c to $1,2,3,4 to $5 (asx dual listing, when i bought it), the rest is history.
Today its A$55?
(Nasdaq will intro *New Investors to gmv =)
Nobody knows what gmv sp will do next 50 days, but i am willing to wait till after Nasdaq listing to see if my gritty wait will be handsomely rewarded.
I noticed you hold A2M and Xero.
Ask yourself why?
And if Gmv fits your investment criteria, then Hold;
if not you must reconsider your position. aimo.
Don't rely on what i say or anyone else on hc chatroom.
Everyone has a his/her reason/motive/agenda for posting.
Its not for me to question why.
Best wishes to all of us in next 50 business days.
I may go offscreen for next few weeks.
Dyor
